Denali Therapeutics CEO Ryan J. Watts Sells Shares
閱讀少於1分鐘
| Reporter Name | Watts Ryan J. |
| Relationship | President and CEO |
| Type | Sell |
| Amount | $7,429,230 |
| SEC Filing | Form 4 |
Denali Therapeutics President and CEO, Ryan J. Watts, sold 495,282 shares of common stock on July 9, 2025, for a total sale amount of $7,429,230. The weighted average sale price per share was $15.00. Following the transaction, Watts directly owns 253,071 shares and indirectly owns 2,202,604 shares through the Watts Family 2015 Trust. The sales were made under a 10b5-1 selling plan dated September 16, 2024.
SEC Filing: Denali Therapeutics Inc. [ DNLI ] - Form 4 - Jul. 11, 2025